Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TYMP | P19971 | 12/20 | 0.45 |
| ▸ | P2RY6 | Q15077 | 5/20 | 0.38 |
| ▸ | P2RY14 | Q15391 | 4/20 | 0.38 |
| ▸ | NT5E | P21589 | 2/20 | 0.38 |
| ▸ | TMIGD3 | P0DMS9 | 1/20 | 0.35 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.35 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL261395 | 0.92 | TYMP (0.46) | TYMPP2RY6P2RY14NT5ETMIGD3 | |
| SCHEMBL29531167 | 0.92 | TYMP (0.46) | TYMPP2RY6P2RY14NT5ETMIGD3 | |
| SCHEMBL6515020 | 0.88 | TYMP (0.49) | TYMPADORA1 | |
| SCHEMBL7261566 | 0.86 | TYMP (0.46) | TYMPP2RY6P2RY14NT5ETMIGD3 | |
| SCHEMBL3065836 | 0.85 | TYMP (0.47) | TYMPP2RY6P2RY14NT5ETMIGD3 | |
| SCHEMBL3065837 | 0.85 | TYMP (0.47) | TYMPP2RY6P2RY14NT5ETMIGD3 | |
| SCHEMBL29254521 | 0.85 | TYMP (0.43) | TYMPP2RY6P2RY14NT5ETMIGD3 | |
| SCHEMBL29254523 | 0.85 | TYMP (0.43) | TYMPP2RY6P2RY14NT5ETMIGD3 | |
| SCHEMBL21552240 | 0.85 | TYMP (0.47) | TYMPP2RY6P2RY14NT5ETMIGD3 | |
| SCHEMBL21552241 | 0.85 | TYMP (0.47) | TYMPP2RY6P2RY14NT5ETMIGD3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6214986-B1 | OLIGONUCLEOTIDE OF DEFINED NUCLEOTIDE SEQUENCE TARGETED TO HUMAN PROTEIN WHICH CONTROLS APOPTOSIS; ALTERS RATIOS OF ISOFORMS IN TISSUE; GENE EXPRESSION INHIBITION; SENSITIZING CELLS TO APOPTOTIC STIMULI | ISIS PHARMACEUTICALS, INC. | 2001-04-10 | — | — | US | disclosed |